Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4651 to 4665 of 7691 results

  1. Magnesium sulfate for neuroprotection: bolus plus infusion compared with bolus alone:- What is the clinical effectiveness of a bolus plus infusion of magnesium sulfate compared with a bolus alone for preventing neurodevelopmental injury in babies born preterm?

    Recommendation ID NG25/4 Question Magnesium sulfate for neuroprotection: bolus plus infusion compared with bolus alone:- What is the clinical

    Research recommendation
    Published
    11 December 2015

  2. Long-term real-world data is needed on AposHealth's clinical effectiveness and cost benefit

    Recommendation ID MTG76/1 Question Long-term real-world data is needed on AposHealth's clinical effectiveness and cost benefit Any

    Research recommendation
    Published
    5 May 2023

  3. Maintaining benefits after successful treatment of anorexia nervosa:- What factors (including comorbidities, personal, social and demographic factors, treatment type,and subsequent relapse prevention interventions) are associated with continued benefit after successful treatment for anorexia nervosa?

    Recommendation ID NG69/5 Question Maintaining benefits after successful treatment of anorexia nervosa:- What factors (including comorbidities

    Research recommendation
    Published
    12 October 2018

  4. Long term real-world data is needed on AposHealth's clinical effectiveness and cost benefit

    Recommendation ID MTG76/2 Question Long term real-world data is needed on AposHealth's clinical effectiveness and cost benefit Any

    Research recommendation
    Published
    5 May 2023

  5. Maintaining the benefits of early intervention in psychosis services after discharge:- How can the benefits of early intervention in psychosis services be maintained once service users are discharged after 3 years?

    Recommendation ID CG178/4 Question Maintaining the benefits of early intervention in psychosis services after discharge:- How can the benefits

    Research recommendation
    Published
    9 June 2015

  6. What are the long-term risks of mesh surgery compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women?

    Recommendation ID NG123/5 Question What are the long-term risks of mesh surgery compared with non-mesh surgery for stress urinary incontinence

    Research recommendation
    Published
    21 June 2019

  7. Long-term safety of ovarian stimulation and ovulation induction for women:- Is there an association between ovulation induction or ovarian stimulation and adverse long-term (over 20 years) effects in women in the UK?

    Recommendation ID CG156/4 Question Long-term safety of ovarian stimulation and ovulation induction for women:- Is there an association

    Research recommendation
    Published
    9 June 2015

  8. Maintenance treatment:- In the maintenance treatment of bipolar disorder, what is the relative effect on quality of life of lithium, an antipsychotic (haloperidol, olanzapine, quetiapine or risperidone), or a combination of lithium and an antipsychotic?

    Recommendation ID CG185/2 Question Maintenance treatment:- In the maintenance treatment of bipolar disorder, what is the relative effect

    Research recommendation
    Published
    9 June 2015

  9. What is the best and most cost-effective management strategy for people whose first surgery for primary hyperparathyroidism is not successful?

    Recommendation ID NG132/2 Question What is the best and most cost-effective management strategy for people whose first surgery for primary

    Research recommendation
    Published
    25 October 2019

  10. What is the effectiveness and safety of sacral nerve stimulation and transanal irrigation compared to symptomatic treatment for people with major low anterior resection syndrome?

    Recommendation ID NG151/2 Question What is the effectiveness and safety of sacral nerve stimulation and transanal irrigation compared to

    Research recommendation
    Published
    10 February 2020

  11. For people with different causes of shoulder pain after stroke, what is the clinical and cost effectiveness of interventions in reducing pain?

    Recommendation ID NG236/5 Question For people with different causes of shoulder pain after stroke, what is the clinical and cost effectiveness

    Research recommendation
    Published
    11 January 2024

  12. Management of smouldering myeloma:- Which combinations of FISH, molecular technologies, bone marrow plasma cell percentage, whole-body imaging, immunophenotype, serum-free light-chain levels or ratio, Hevylite, paraprotein levels, immunoparesis, and International Staging System (ISS) are most effective at risk stratification for people with smouldering myeloma? What is the comparative effectiveness of fixed duration treatment (with or without bone-directed therapy), continuous treatment (with or without bone-directed therapy) and no treatment (with or without bone-directed therapy) for people with smouldering myeloma?

    Recommendation ID NG35/3 Question Management of smouldering myeloma:- Which combinations of FISH, molecular technologies, bone marrow plasma

    Research recommendation
    Published
    5 April 2016

  13. Management of stable angina in people with evidence of ischaemia on non-invasive functional testing:- Do people with stable angina and evidence of reversible ischaemia on noninvasive functional testing who are on optimal drug treatment benefit from routine coronary angiography with a view to revascularisation?

    Recommendation ID CG126/2 Question Management of stable angina in people with evidence of ischaemia on non-invasive functional testing:-

    Research recommendation
    Published
    9 June 2015

  14. Management strategies to reduce the risk of symptomatic urinary tract infections:- In people with neurogenic lower urinary tract dysfunction, which management strategies (including the use of prophylactic antibiotics and various invasive and non-invasive techniques to aid bladder drainage) reduce the risk of symptomatic urinary tract infections?

    Recommendation ID CG148/3 Question Management strategies to reduce the risk of symptomatic urinary tract infections:- In people with neurogenic

    Research recommendation
    Published
    9 June 2015

  15. What is the most clinically and cost-effective treatment for diverticular disease?

    Recommendation ID NG147/3 Question What is the most clinically and cost-effective treatment for diverticular disease? Any explanatory

    Research recommendation
    Published
    10 February 2020